REPLIGEN CORP Inventory Valuation Reserves
REPLIGEN CORP (RGEN) had Inventory Valuation Reserves of $455.00 thousand as of 2017-12-31, per its 10-K filed 2018-02-22.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryValuationReserves · last filed 2018-02-22
- 2017-12-31: Inventory Valuation Reserves $455.00K.
- 2017-09-30: Inventory Valuation Reserves $406.00K.
- 2017-06-30: Inventory Valuation Reserves $406.00K.
- 2017-03-31: Inventory Valuation Reserves $385.00K.
| Period end | Inventory Valuation Reserves |
|---|---|
| 2017-12-31 | $455.00K 10-K · filed 2018-02-22 |
| 2017-09-30 | $406.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $406.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $385.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $435.00K 10-K · filed 2018-02-22 |
| 2016-09-30 | $476.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $343.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $343.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $343.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $328.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $57.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $78.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $78.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $77.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $182.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $182.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $183.00K 10-K · filed 2015-03-17 |
| 2013-09-30 | $156.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $151.00K 10-Q · filed 2013-08-07 |
| 2013-03-31 | $154.00K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $154.00K 10-K · filed 2014-03-14 |
| 2011-12-31 | $149.00K 10-K · filed 2013-03-15 |
| 2011-03-31 | $50.00K 10-K · filed 2013-03-15 |
| 2010-12-31 | $50.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |